Vijay Hegde

Texas Tech University

H指数:26

被引数:2,578

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metabolic dysfunction-associated steatotic liver disease—a review of the cardiometabolic perspectives and treatments in children

代谢功能障碍相关脂肪性肝病——儿童患者的心代谢视角和治疗综述

International Journal of Obesity

IF3.8

2026-09-230

PRE

Mitochondrial Dysfunction in Alzheimer’s Disease and Mitochondria-Targeted Therapeutics

阿尔茨海默病中的线粒体功能障碍及靶向线粒体的治疗策略

Cells

IF5.2

2026-05-280

Reproducibility and Sex Differences in a STZ–High-Fat Diet Model of MASLD and Early Hepatocarcinogenesis

可重复性与性别差异：STZ–高脂饮食模型中的MASLD与早期肝细胞癌发生

International Journal of Molecular Sciences

IF4.9

2026-04-010

OAAI

Postmenopausal Sarcopenia and Alzheimer's disease: The interplay of Mitochondria, Insulin resistance, and Myokines

绝经后肌少症与阿尔茨海默病：线粒体、胰岛素抵抗和肌细胞因子的相互作用

Neuroscience & Biobehavioral Reviews

IF0

2025-11-290

OAAI

Pre-clinical studies show anti-diabetic effect of INSPARIN, a protein derived from the E4orf1 gene of a human adenovirus

临床前研究显示，INSPARIN（一种来源于人腺病毒E4orf1基因的蛋白质）具有抗糖尿病作用。

Nutrition & Diabetes

IF5.2

2025-11-240

OAAI

Preclinical Studies Indicate That Insparin Is a New Class of Antidiabetes Agent

DIABETES

IF7.5

2024-06-140

PRE

Peripheral Mitochondrial Dysfunction: A Potential Contributor to the Development of Metabolic Disorders and Alzheimer's Disease

BIOLOGY-BASEL

IF3.5

2023-07-1917

OAAI

Branched-Chain Amino Acids Are Linked with Alzheimer's Disease-Related Pathology and Cognitive Deficits

CELLS

IF5.2

2022-11-0728

OAAI

Protective Effects of Chaya against Mitochondrial and Synaptic Toxicities in the Type 2 Diabetes Mouse Model TallyHO

CELLS

IF5.2

2022-02-214

OAAI

Cardiometabolic Modification of Amyloid Beta in Alzheimer's Disease Pathology

阿尔茨海默病病理学中 β 淀粉样蛋白的心脏代谢修饰

FRONTIERS IN AGING NEUROSCIENCE

IF4.5

2021-08-236

OAAI

Antidiabetic E4orf1 protein prevents hepatic steatosis and reduces markers of aging-related cellular damage in high fat fed older mice

BMJ OPEN DIABETES RESEARCH & CARE

IF4.1

2021-05-037

OAAI

The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19

ACTA DIABETOLOGICA

IF2.9

2021-02-1552

OAAI

Neural Underpinnings of Obesity: The Role of Oxidative Stress and Inflammation in the Brain

ANTIOXIDANTS

IF6.6

2020-10-2035

OAAI

E4orf1, an Adeno-viral protein, attenuates renal lipid accumulation in high fat fed mice: A novel approach to reduce a key risk factor for chronic kidney disease

HELIYON

IF3.6

2020-10-014

OAAI

Obesity and Diabetes Mediated Chronic Inflammation: A Potential Biomarker in Alzheimer's Disease

JOURNAL OF PERSONALIZED MEDICINE

IF3

2020-05-2241

OAAI

Role of E4orf1 in attenuation of renal fat accumulation and injury in mice exposed to high fat diet

FASEB JOURNAL

IF4.2

2020-04-212

PRE

Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer's Disease?

JOURNAL OF ALZHEIMERS DISEASE

IF3.1

2019-12-2722

PREAI

A MetAP2 inhibitor blocks adipogenesis, yet improves glucose uptake in cells

ADIPOCYTE

IF3.1

2019-07-0212

OAAI

Twenty-five years of research about adipogenic adenoviruses: A systematic review

OBESITY REVIEWS

IF7.4

2018-12-1821

PREAI

Transdisciplinary Research on Energetics and Cancer: From Adipose Tissue to the American Society of Clinical Oncology (ASCO) Summit Recommendations

OBESITY

IF4.7

2017-10-310

OAAI

Vijay Hegde

个人简介

教育背景

工作经历

荣誉奖项

研究方向